Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study.
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
11
References
10
Citations
NaN
KQI